Home › IGA Glomerulonephritis › Iowa
IGA Glomerulonephritis clinical trials in Iowa
3 studies for IGA Glomerulonephritis are looking for participants at sites in Iowa.
Cities in Iowa
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Iowa City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06989359Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- University of Iowa Hospitals and Clinics, Iowa City
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Univ Of Iowa Hospitals And Clinics, Iowa City
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07146906From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.